CEFAZOLIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Cefazolin Sodium patents expire, and what generic alternatives are available?
Cefazolin Sodium is a drug marketed by Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Dr Reddys, Facta Farma, Fresenius Kabi Usa, Glaxosmithkline, Hikma, Hikma Farmaceutica, Hospira, Hospira Inc, Qilu, Samson Medcl, Sandoz, Steri Pharma, Teva Pharms, and Hq Spclt Pharma. and is included in thirty-four NDAs.
The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin Sodium
A generic version of CEFAZOLIN SODIUM was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFAZOLIN SODIUM?
- What are the global sales for CEFAZOLIN SODIUM?
- What is Average Wholesale Price for CEFAZOLIN SODIUM?
Summary for CEFAZOLIN SODIUM
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 34 |
| Finished Product Suppliers / Packagers: | 19 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Clinical Trials: | 8 |
| Patent Applications: | 2,824 |
| What excipients (inactive ingredients) are in CEFAZOLIN SODIUM? | CEFAZOLIN SODIUM excipients list |
| DailyMed Link: | CEFAZOLIN SODIUM at DailyMed |
Recent Clinical Trials for CEFAZOLIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, Riverside | Phase 2/Phase 3 |
| HK Surgical, Inc. | Phase 2/Phase 3 |
| University of British Columbia | Early Phase 1 |
Pharmacology for CEFAZOLIN SODIUM
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFAZOLIN SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for CEFAZOLIN SODIUM
US Patents and Regulatory Information for CEFAZOLIN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Farmaceutica | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065047-002 | Sep 18, 2001 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 064170-002 | Mar 18, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qilu | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 203661-001 | Dec 28, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
